Strata Critical Medical, Inc.·4

Mar 10, 5:28 PM ET

Heyburn William A. 4

4 · Strata Critical Medical, Inc. · Filed Mar 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Strata Critical Medical (SRTA) Co‑CEO/CFO Heyburn Sells 31,314 Shares

What Happened
William A. Heyburn, Co‑CEO, CFO and a director of Strata Critical Medical (SRTA), had 31,314 shares withheld by the company to satisfy tax withholding tied to the vesting of restricted stock units. The withholding is reported as a disposition at $4.54 per share, totaling $142,166. This was a tax-withholding transaction (not an open-market sale).

Key Details

  • Transaction date: 2026-03-08; filing date: 2026-03-10 (Form 4 filed timely).
  • Shares withheld/disposed: 31,314 at $4.54 each; total value reported $142,166.
  • Shares owned after transaction: not specified in the filing.
  • Footnote: F1 — issuer withheld shares to satisfy tax withholding obligations on RSU vesting.
  • Transaction code: F (tax withholding), a disposition rather than a purchase or deliberate market sale.

Context
This was a routine tax-withholding/cashless settlement related to RSU vesting and does not necessarily indicate a change in insider sentiment. Such transactions reduce the insider's reported share count but are common when equity awards vest.

Insider Transaction Report

Form 4
Period: 2026-03-08
Heyburn William A.
DirectorCo-CEO and CFO
Transactions
  • Tax Payment

    Class A common stock, $0.0001 par value per share

    [F1]
    2026-03-08$4.54/sh31,314$142,1661,336,774 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Signature
/s/ Melissa M. Tomkiel, as attorney-in-fact for William A. Heyburn|2026-03-10

Documents

1 file
  • 4
    wk-form4_1773178123.xmlPrimary

    FORM 4